Lenalidomide/revlimid dose
Active Purchase Order Awarded Last action
- Contract number
- 36C25226P0111
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $2,583,452
Award facts
- Opportunity
-
- Lenalidomide/Revlimid - Brand name or Equal Solicitation · 36C25226Q0108 · Posted Nov 24, 2025
- Contract value 100% obligated
- $2,583,451.63 Current and potential, with all options
- Completion date 84% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a $2.58 million firm fixed-price purchase order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide/Revlimid, a critical pharmaceutical product used in cancer treatment. The contract was awarded on December 15, 2025, with an ultimate completion date of December 14, 2026, and will be performed at Exelan's facility in Boca Raton, Florida. This procurement originated from a competitive Request for Quote solicitation issued by the Clement J. Zablocki Veterans Affairs Medical Center in Milwaukee, Wisconsin, with no set-aside designation, allowing all qualified vendors to compete. The contract represents part of the VA's ongoing efforts to ensure reliable pharmaceutical supply chains for its healthcare system.
Exelan Pharmaceuticals, a foreign-owned pharmaceutical company specializing in manufacturing, distributing, and repackaging generic and branded pharmaceutical products, is well-positioned to fulfill this requirement through its extensive experience serving federal healthcare agencies including the VA, Department of Defense, and Bureau of Prisons. The company operates as a Federal Supply Schedule contractor and holds multiple Indefinite Delivery Contracts with federal agencies, demonstrating a proven track record of delivering diverse pharmaceutical products at scale. This award continues the VA's reliance on experienced pharmaceutical vendors to support patient care across its healthcare network.
Quick answers
Who was awarded contract 36C25226P0111?
36C25226P0111 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on December 15, 2025.
How much is contract 36C25226P0111 worth?
The government has obligated $2,583,452 on 36C25226P0111.
Was contract 36C25226P0111 competed?
The extent of competition for 36C25226P0111 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award